Highlights
ASX: IMU       IMUGENE LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.035   -0.001 (2.78%)  0.034 - 0.037  20,473,476

Overview

 
Avg Volume (4 weeks):22,532,878
4 Weeks Range:0.029 - 0.039
4 Weeks Price Volatility (%):
60.00%
52 Weeks Range:0.013 - 0.063
52 Weeks Price Volatility (%):
44.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Imugene Limited is an immuno-oncology focused biopharmaceutical company. The Company is engaged in the research and development of human epidermal growth factor receptor 2 positive (HER2 +ve), and gastric and breast cancer vaccines. The Company is also engaged in the research, development and commercialization of health technologies. HER-Vaxx is a cancer immunotherapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. HER-Vaxx has completed a Phase I clinical trial with over 10 HER-2 positive patients with metastatic breast cancer. It was shown in pre-clinical studies and in one Phase 1 study to stimulate a potent polyclonal antibody response to HER-2/neu. HER-Vaxx has stimulated the production of HER-2 antibodies in early-stage cancer patients enrolled in the initial clinical trial. The Company is also developing mimotope-based immunotherapies against validated and oncology targets.

  Be the first to like this.
 


 

469  746  664  2399 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 XCD 0.015+0.003 
 AZI 0.009-0.001 
 CZN 0.004+0.001 
 AEE 0.007+0.001 
 RXL 0.029+0.001 
 MCT 0.005+0.001 
 LIN 0.046-0.003 
 FMG 12.08+0.25 
 MRQ 0.015+0.001 
 BLK 0.0110.00 
Partners & Brokers